Insomnia is a common sleep disorder that can make it difficult for a person to fall asleep or stay asleep.

People with this condition are also likely to wake up very early and not be able to go back to sleep. They may continue to feel tired even after waking up.

“Insomnia, which is commonly associated with stress and anxiety, may also play a role in the risk and survival rates of ovarian cancer patients. “Research shows that disturbed sleep patterns can increase inflammation and weaken the immune system, potentially promoting cancer development,” Dr. Kinjal Kothari, Associate Consultant – Obstetrics and Gynaecology, Manipal Hospital, Goa, told IANS.A recent study published in The Lancet suggests that treating insomnia in high-grade ovarian cancer may improve survival. The study also proposed that treating insomnia could prevent ovarian cancer.

The incidence and prevalence of cancer is on an increasing trend. With this trend, there is a strong need to study disease patterns and ways to improve patient survival and quality of life.

“Sleep disorders are common in cancer patients.This may result in insomnia or abnormal sleep-wake cycles; Probably more than half of the patients are affected. The patient's quality of life is negatively impacted,” says Dr. Karthik KS, consultant surgical oncology, KMC Hospital, Mangalore, told IANS.

Sleep symptoms may also be caused by the psychological effects of the disease (such as anxiety and depression) on the patient and family, the doctor said.

“Patients may lose sleep due to cancer pain and pressure symptoms. Side effects and complications of treatment such as nausea and vomiting can also affect sleep,” said Dr. Karthik.Dr. M.A. Raja, director and senior consultant - medical oncology, MGM Cancer Institute, Chennai, told IANS that sleep disorders, such as insomnia, are known to increase the risk of breast and ovarian cancer and negatively impact their prognosis. .

“Sleep is essential for the human body, it is intricately involved in endocrine, metabolic, and immunoregulatory pathways, which are also implicated in various cancers. These shared pathways may lead to an increased risk of sleep disturbances in cancer patients, with insomnia being the most common,” the doctor said.

Furthermore, insomnia often leads to poor mental health, which may indirectly affect treatment adherence and overall well-being during cancer therapy. Understanding this relationship underscores the importance of addressing sleep disturbances in cancer care."Developing tailored interventions such as cognitive behavioral therapy for insomnia could potentially improve outcomes for ovarian cancer patients by promoting better sleep and increasing resilience against the disease," said Dr. Kinzel.